Inventor · disambiguated record
Etienne Thoreau
Also filed as: THOREAU ETIENNE
19 granted patents·3 pending applications·43 citations·filing 1997–2020
90Inventor score
Top patents by PatentIndex Score
22 records- 0184US10246440B2Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR γ (T))GALDERMA RES & DEV·Filed 2015·Granted Apr 2, 2019·2 cites·8 claims
- 0282US7625914B2Compounds that modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2005·Granted Dec 1, 2009·5 cites·38 claims
- 0376US8049034B2Biphenyl compound selective agonists of gamma RAR receptorsGALDERMA RES & DEV·Filed 2008·Granted Nov 1, 2011·2 cites·15 claims
- 0470US7312249B2Vitamin D analoguesGALDERMA RES & DEV·Filed 2005·Granted Dec 25, 2007·1 cites·162 claims
- 0568US5910508APolycyclic polyenic compounds and pharmaceutical/cosmetic compositions comprised thereofCIRD GALDERMA·Filed 1997·Granted Jun 8, 1999·27 cites·18 claims
- 0666US10752617B2Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))GALDERMA RES & DEV·Filed 2019·Granted Aug 25, 2020·0 cites·19 claims
- 0765US8022079B2Methods of modulating PPAR gamma-type receptorsGALDERMA RES & DEV·Filed 2009·Granted Sep 20, 2011·0 cites·34 claims
- 0865US7968560B2Compounds that modulate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprising said compoundsGALDERMA RES & DEV·Filed 2009·Granted Jun 28, 2011·0 cites·31 claims
- 0961US7973063B2Methods for activating PPAR gamma-type receptorsGALDERMA RES & DEV·Filed 2009·Granted Jul 5, 2011·0 cites·37 claims
- 1058US10618890B2Benzimidazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))GALDERMA RES & DEV·Filed 2015·Granted Apr 14, 2020·0 cites·13 claims
- 1158US10550110B2Tetrahydroquinoline sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (t))GALDERMA RES & DEV·Filed 2015·Granted Feb 4, 2020·0 cites·20 claims
- 1256US8106235B2Biphenyl compound selective agonists of gamma RAR receptorsBIADATTI THIBAUD·Filed 2008·Granted Jan 31, 2012·0 cites·11 claims
- 1356US7626054B2Biaromatic compounds which activate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2006·Granted Dec 1, 2009·0 cites·56 claims
- 1452US11518767B2MTOR inhibitor compoundsGALDERMA RES & DEV·Filed 2020·Granted Dec 6, 2022·0 cites·10 claims
- 1551US11731973B2Substituted pyrazolo[3,4-d]pyrimidines as mTOR inhibitorsGALDERMA RES & DEV·Filed 2020·Granted Aug 22, 2023·0 cites·17 claims
- 1651US8362082B2Biphenyl compound selective agonists of gamma RAR receptorsGALDERMA RES & DEV·Filed 2011·Granted Jan 29, 2013·0 cites·12 claims
- 1745US2006058351A1Novel ligands that modulate LXR-type receptors and cosmetic/pharmaceutical applications thereofGALDERMA RES & DEV·Filed 2005·Application pending·0 cites
- 1844US5905088AHeterocyclic biaryl compounds and pharmaceutical/cosmetic compositions comprised thereofCIRD GALDERMA·Filed 1997·Granted May 18, 1999·6 cites·55 claims
- 1939US2006052627A1Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2005·Application pending·0 cites
- 2038US2006035969A1Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2005·Application pending·0 cites
- 2136US10457637B2Benzenesulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (RORγ(T))GALDERMA RES & DEV·Filed 2015·Granted Oct 29, 2019·0 cites·15 claims
- 2235US10246422B2Heterocyclic compounds and use thereof in medicine and in cosmeticsGALDERMA RES & DEV·Filed 2015·Granted Apr 2, 2019·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Etienne Thoreau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →